| 2026-05-21 |
13G |
REPL / Replimune Group, Inc.
|
|
|
6,252,651 |
|
|
|
| 2026-02-17 |
13G/A |
LENZ / LENZ Therapeutics, Inc.
|
|
1,951,875 |
0 |
|
|
|
| 2025-11-14 |
13G/A |
SMLR / Semler Scientific, Inc.
|
|
976,112 |
0 |
|
|
|
| 2025-11-14 |
13G/A |
ITOS / iTeos Therapeutics, Inc.
|
|
1,942,959 |
0 |
|
|
|
| 2025-07-25 |
13G |
ITOS / iTeos Therapeutics, Inc.
|
|
1,442,959 |
1,942,959 |
|
|
|
| 2025-07-16 |
13G |
SMLR / Semler Scientific, Inc.
|
|
|
976,112 |
|
|
|
| 2025-06-04 |
13G |
ITOS / iTeos Therapeutics, Inc.
|
|
|
1,442,959 |
|
|
|
| 2025-05-20 |
13G/A |
AFMDQ / Affimed N.V.
|
|
14,858,982 |
0 |
|
|
|
| 2025-02-14 |
13G/A |
PYXS / Pyxis Oncology, Inc.
|
|
4,345,228 |
359,231 |
|
|
|
| 2024-07-29 |
13G |
LENZ / LENZ Therapeutics, Inc.
|
|
|
1,951,875 |
|
|
|
| 2024-02-14 |
13G/A |
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
|
|
2,264,801 |
844,235 |
|
|
|
| 2024-02-14 |
13G/A |
AFMD / Affimed N.V.
|
|
12,882,610 |
14,858,982 |
|
|
|
| 2024-01-26 |
13G |
PYXS / Pyxis Oncology, Inc.
|
|
|
4,345,228 |
|
|
|
| 2023-02-14 |
13G/A |
FSTX / F-star Therapeutics Inc
|
|
1,834,360 |
52,509 |
|
|
|
| 2023-02-14 |
13G/A |
AFMD / Affimed N.V.
|
|
7,722,106 |
12,882,610 |
|
|
|
| 2023-02-14 |
13G/A |
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
|
|
2,164,801 |
2,264,801 |
|
|
|
| 2023-02-14 |
13G/A |
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
|
|
2,164,801 |
2,264,801 |
|
|
|
| 2023-02-14 |
13G/A |
AFMD / Affimed N.V.
|
|
7,722,106 |
12,882,610 |
|
|
|
| 2023-02-14 |
13G/A |
FSTX / F-star Therapeutics Inc
|
|
1,834,360 |
52,509 |
|
|
|
| 2022-02-14 |
13G/A |
AFMD / Affimed N.V.
|
|
6,450,000 |
7,722,106 |
|
|
|
| 2022-02-14 |
13G/A |
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
|
|
1,861,833 |
2,164,801 |
|
|
|
| 2022-02-14 |
13G/A |
FSTX / F-star Therapeutics Inc
|
|
494,360 |
1,834,360 |
|
|
|
| 2022-02-14 |
13G/A |
COGT / Cogent Biosciences, Inc.
|
|
1,252,250 |
0 |
|
|
|
| 2021-04-14 |
13G |
AFMD / Affimed N.V.
|
|
|
6,450,000 |
|
|
|
| 2021-04-09 |
13G/A |
FSTX / F-star Therapeutics Inc
|
|
407,567 |
494,360 |
|
|
|
| 2021-02-16 |
13G/A |
MYO / Myomo, Inc.
|
|
140,000 |
104,755 |
|
|
|
| 2021-02-16 |
13G/A |
COGT / Cogent Biosciences, Inc.
|
|
2,400,000 |
1,252,250 |
|
|
|
| 2021-02-16 |
13G/A |
FDMT / 4D Molecular Therapeutics, Inc.
|
|
1,438,487 |
1,100,000 |
|
|
|
| 2021-02-16 |
13G/A |
VSTM / Verastem, Inc.
|
|
10,068,243 |
0 |
|
|
|
| 2021-02-16 |
13G/A |
FSTX / F-star Therapeutics Inc
|
|
1,142,900 |
407,567 |
|
|
|
| 2021-02-16 |
13G/A |
STRO / Sutro Biopharma, Inc.
|
|
2,014,687 |
1,144,979 |
|
|
|
| 2021-02-16 |
13G/A |
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
|
|
1,144,633 |
1,861,833 |
|
|
|
| 2020-12-23 |
13G |
FDMT / 4D Molecular Therapeutics, Inc.
|
|
|
1,438,487 |
|
|
|
| 2020-08-25 |
13G |
STRO / Sutro Biopharma, Inc.
|
|
2,014,687 |
2,014,687 |
|
|
|
| 2020-08-24 |
13G |
STRO / Sutro Biopharma, Inc.
|
|
|
2,014,687 |
|
|
|
| 2020-07-16 |
13G |
COGT / Cogent Biosciences, Inc.
|
|
|
2,400,000 |
|
|
|
| 2020-07-13 |
13G |
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
1,144,633 |
|
|
|
| 2020-03-06 |
13G/A |
VSTM / Verastem, Inc.
|
|
10,068,243 |
10,068,243 |
|
|
|
| 2020-02-24 |
13G |
MYO / Myomo, Inc.
|
|
|
140,000 |
|
|
|
| 2020-02-14 |
13G/A |
KPTI / Karyopharm Therapeutics Inc.
|
|
3,945,200 |
0 |
|
|
|
| 2020-01-21 |
13G |
VSTM / Verastem, Inc.
|
|
0 |
10,068,243 |
|
|
|
| 2020-01-06 |
13G |
FSTX / F-star Therapeutics Inc
|
|
|
1,142,900 |
|
|
|
| 2019-02-14 |
13G/A |
KPTI / Karyopharm Therapeutics Inc.
|
|
2,732,125 |
3,945,200 |
|
|
|
| 2018-03-15 |
13G |
CORI / Corium International, Inc.
|
|
|
1,914,265 |
|
|
|
| 2018-02-14 |
13G/A |
VSTM / Verastem, Inc.
|
|
2,860,786 |
0 |
|
|
|
| 2018-01-26 |
13G |
KPTI / Karyopharm Therapeutics Inc.
|
|
|
2,732,125 |
|
|
|
| 2017-07-20 |
13G |
VSTM / Verastem, Inc.
|
|
|
2,860,786 |
|
|
|
| 2017-01-30 |
13G/A |
ONCS / OncoSec Medical Inc
|
|
1,292,614 |
0 |
|
|
|
| 2017-01-30 |
13G/A |
PATI / Patriot Transportation Holding, Inc.
|
|
|
0 |
|
|
|
| 2016-02-16 |
13G/A |
TRIL / Tidal Trust II - Defiance Trillion Dollar Club Index ETF
|
|
451,883 |
370,537 |
|
|
|
| 2016-02-16 |
13G/A |
ONCS / OncoSec Medical Inc
|
|
1,272,614 |
1,292,614 |
|
|
|
| 2016-02-16 |
13G/A |
CARA / Cara Therapeutics, Inc.
|
|
1,795,000 |
622,140 |
|
|
|
| 2016-02-16 |
13G/A |
AGTC / Applied Genetic Technologies Corp
|
|
|
246,005 |
|
|
|
| 2015-06-18 |
13G |
ONCS / OncoSec Medical Inc
|
|
|
1,272,614 |
|
|
|
| 2015-04-20 |
13G |
CARA / Cara Therapeutics, Inc.
|
|
|
1,795,000 |
|
|
|
| 2015-04-02 |
13G |
TRIL / Tidal Trust II - Defiance Trillion Dollar Club Index ETF
|
|
|
451,883 |
|
|
|
| 2015-02-17 |
13G/A |
AGTC / Applied Genetic Technologies Corp
|
|
|
1,364,941 |
|
|
|
| 2014-04-10 |
13G |
AGTC / Applied Genetic Technologies Corp
|
|
|
1,082,240 |
|
|
|
| 2014-02-14 |
13G/A |
SGMO / Sangamo Therapeutics, Inc.
|
|
|
2,900,000 |
|
|
|
| 2014-02-14 |
13G/A |
STML / Stemline Therapeutics, Inc.
|
|
|
506,699 |
|
|
|
| 2014-02-14 |
13G/A |
CLDX / Celldex Therapeutics, Inc.
|
|
|
1,025,000 |
|
|
|
| 2014-02-14 |
13G/A |
ARWR / Arrowhead Pharmaceuticals, Inc.
|
|
|
791,306 |
|
|
|
| 2014-02-14 |
13G/A |
GERN / Geron Corporation
|
|
|
225,000 |
|
|
|
| 2013-10-17 |
13G |
GERN / Geron Corporation
|
|
|
7,480,105 |
|
|
|
| 2013-10-16 |
13G |
ARWR / Arrowhead Pharmaceuticals, Inc.
|
|
|
1,817,717 |
|
|
|
| 2013-09-30 |
13G |
SGMO / Sangamo Therapeutics, Inc.
|
|
|
3,572,336 |
|
|
|
| 2013-02-14 |
13G/A |
IRWD / Ironwood Pharmaceuticals, Inc.
|
|
|
784,381 |
|
|
|
| 2013-02-07 |
13G |
STML / Stemline Therapeutics, Inc.
|
|
|
583,275 |
|
|
|
| 2012-12-28 |
13G |
CLDX / Celldex Therapeutics, Inc.
|
|
|
3,804,646 |
|
|
|
| 2012-02-14 |
13G/A |
MDCO / Medicines Company
|
|
|
748,499 |
|
|
|
| 2012-02-14 |
13G/A |
IRWD / Ironwood Pharmaceuticals, Inc.
|
|
|
6,955,317 |
|
|
|